There are many forms of interstitial lung disease (ILD), which is sometimes called pulmonary fibrosis. The evaluation, when you come to our clinic, focuses on determining what type of lung disease you have. Once we do this, we can establish an individualized treatment plan. Treatment may include medications but also focuses on exercise, nutrition, oxygen (when necessary), and quality of life.
Specific forms of ILD that we see include: idiopathic pulmonary fibrosis (IPF), connective tissue disease-associated ILD (including lung disease related to rheumatoid arthritis, scleroderma/ systemic sclerosis, dermatomyositis and polymyositis, Sjogren's syndrome, and lupus), as well as sarcoidosis, hypersensitivity pneumonitis and other forms of occupational lung disease.
We have a multidisciplinary program with specialists in pulmonology, radiology, pathology, occupational medicine and rheumatology. Cases are discussed in our group weekly with a goal of finding the correct diagnosis and determining the most appropriate treatment plan. We offer clinical trial enrollment for interested patients and have several open trials for patients with idiopathic pulmonary fibrosis and scleroderma lung disease.
- Connective Tissue Diseases
- Lung Diseases
- Pulmonary Fibrosis
- Lung Diseases, Interstitial
Accepts new patients? Yes
Patient Type: Adult
Referrals: From patients or physicians
Patient Care Organizations
Critical Care Medicine (Internal Medicine) AB of Internal Medicine (2006)
|Diseases of the Lung, Diseases of the Respiratory System, Diseases of the Respiratory Systems||A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis|
|Diseases of the Respiratory System, Diseases of the Respiratory Systems||A Phase 2 Trial to Evaluate the Efficacy of PRM-151 in Subjects with Idiopathic Pulmonary Fibrosis|
|Diseases of the Respiratory Systems||(GB28547) Lebrikizumab|
|Diseases of the Respiratory Systems||(FG-3019-067) Evaluate the Safety and Efficacy of FG-3019 in Patients with IPF|